....2017.05.024 28991543 chronic obstructive pulmonary disease drug therapy fibrosis infection inflammation Pulmonary infections are a leading cause of mortality worldwide. According to the World Health Organization, pneumonia is considered the most common cause of mortality in children under...

... understand more about the role of this intriguing molecule in the treatment of cardiovascular disease. 15 9 2010 27 10 2010 29 10 2010 © The Authors Journal compilation © 2011 Biochemical Society 2011 cardiovascular disease cardioprotection drug therapy hydrogen sulfide (H 2 S...

... Society and the Medical Research Society © 2002 2002 drug therapy nitric oxide S-nitrosoalbumin platelet thiols 99Clinical Science (2002) 102, 99 105 (Printed in Great Britain) + R E V I E W Potential therapeutic uses for S-nitrosothiols G. RICHARDSON and N. BENJAMIN Department of Clinical...

... on to develop a proposal for a Phase I11 study of HU in SCA. This trial, which has since come to be referred to as the Multi- Key words: drug therapy, haemoglobinopathies, physical activity. Abbreviations: DEXA, dual-energy X-ray absorptiometry; GCRC, General Clinical Research Center; HU, hydroxyurea; MSH...

... women classified as hypertensive had died during the 6 years interval since the first examination, both from myocardial infarction. The death rate was similar to the population sample as a whole. © 1976 The Biochemical Society and the Medical Research Society 1976 drug therapy females...

... of these compounds, which were released in association with liposomal lipid, in draining lymph nodes. 27 11 1974 © 1975 The Biochemical Society and the Medical Research Society 1975 chemotherapy drug therapy liposomes Clinical Science and Molecular Medicine (1975) 49 99-106. Liposomes...